FDA-Approved Peptides Require a Prescription Several peptide-based drugs have completed the full FDA approval process and are available only by prescription: Drug Name Active Peptide Approved For Year Approved Ozempic / Wegovy Semaglutide Type 2 diabetes / Chronic weight management 2017 / 2021 Mounjaro / Zepbound Tirzepatide Type 2 diabetes / Chronic weight management 2022 / 2023 Forteo Teriparatide Osteoporosis 2002 Egrifta / Egrifta WR Tesamorelin HIV-associated lipodystrophy 2010 / 2025 Scenesse Afamelanotide Erythropoietic protoporphyria 2019 These compounds went through Phase I, II, and III clinical trials, submitted New Drug Applications (NDAs), and received FDA approval
Symptoms include abdominal distention, vomiting, nausea, constipation and anorexia
The data was then interpreted and discussed, included into specific databases, where correlations and statistics were performed, in order to obtain conclusions concerning the GPx enzyme as a biomarker of oxidative stress and objective therapeutic indications for reducing the level of oxidative stress and respectively cellular oxidation
Elucidation of the vasoactive intestinal peptide pharmacophore for VPAC(2) receptors in human and rat and comparison to the pharmacophore for VPAC(1) receptors
Research has explored the use of T1 as an adjunctive therapy in various viral, bacterial, and chronic infectious conditions due to its ability to enhance immune responsiveness
Peptide-induced IGF rises could correspond to improved follicular environments and increased potential embryo quality in an assisted reproduction context
